MARKET

LVGO

LVGO

Livongo Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

128.06
-16.47
-11.40%
After Hours: 132.72 +4.66 +3.64% 18:55 08/05 EDT
OPEN
149.90
PREV CLOSE
144.53
HIGH
150.00
LOW
124.13
VOLUME
31.53M
TURNOVER
--
52 WEEK HIGH
150.00
52 WEEK LOW
15.12
MARKET CAP
12.53B
P/E (TTM)
-254.9472
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LVGO stock price target is 102.36 with a high estimate of 132.00 and a low estimate of 55.00.

EPS

LVGO News

More
Livongo shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also announced an $18.5 billion merger agreement with Teladoc Health.
Benzinga · 9h ago
Teladoc, Livongo Health Merger Valued At $18.5B
Teladoc Health Inc (NYSE: TDOC) shares are trading lower on Wednesday after the company announced a merger agreement with Livongo Health (NASDAQ: LVGO).
Benzinga · 11h ago
Teladoc, Livongo Health Merger Valued At $18.5B
Teladoc Health Inc (NYSE: TDOC) shares are trading lower on Wednesday after the company announced a merger agreement with Livongo Health (NASDAQ: LVGO).
Benzinga · 11h ago
Livongo shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also announced an $18.5 billion merger agreement with Teladoc Health.
Benzinga · 12h ago
UPDATE: Under Terms Of The Agreement, Each Livongo Share To Be Exhanged For 0.5920 Shares Of Teladoc Plus Cash Consideration Of $11.33/Share
Benzinga · 12h ago
UPDATE: Under Terms Of The Agreement, Each Livongo Share To Be Exhanged For 0.5920 Shares Of Teladoc Plus Cash Consideration Of $11.33/Share
Benzinga · 12h ago
Teladoc Health And Livongo Enter Definitive $18.5B Merger Agreement
The only consumer centered virtual care platform for full spectrum of health needs to address accelerating consumer and client demand   Combination of highly complementary leaders in virtual care and chronic
Benzinga · 12h ago
Livongo Health Q2 Adj. EPS $0.11 Beats $0.01 Estimate, Sales $91.90M Beat $86.74M Estimate
Livongo Health (NASDAQ:LVGO) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.01 by 1000 percent. This is a 123.91 percent increase over losses of $(0.46) per share from the
Benzinga · 12h ago

Industry

Medical Equipment, Supplies & Distribution
+0.92%
Healthcare Equipment & Supplies
+0.81%

Hot Stocks

Symbol
Price
%Change

About LVGO

Livongo Health, Inc. is a consumer digital health company. The Company offers Enter Livongo platform, which leverages data science and technology, creates a personalized experience for people with chronic conditions. The Company focuses on developing an approach for diabetes management that combines technology with coaching. The Company’s Livongo platform offers a range of solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management and Livongo for Behavioral Health by myStrength. The Company uses a digital approach to delivering evidence-based interventions including cognitive behavioral therapy, acceptance and commitment therapy, positive psychology, mindfulness, and motivational interviewing to help resolve clinical conditions, build resiliency, manage stress, improve mood, sleep better, or simply find daily inspiration.
More

Webull offers kinds of Livongo Health Inc stock information, including NASDAQ:LVGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LVGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LVGO stock methods without spending real money on the virtual paper trading platform.